Best EHA Podcasts (2024)

1
EHA 2024 Recap: Optimizing the Relapsed/Refractory CLL Treatment Pathway 37:22

8d ago37:22

37:22

How can you optimize the treatment pathway for relapsed or refractory chronic lymphocytic leukemia (CLL)? Join the experts as they delve into the latest updates from EHA 2024. Credit available for this activity expires: 07/31/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001409 ?ecd=bdc_podcast_libsyn_msc…

1
Updates in the treatment of SCD and thalassemia from EHA 2024: key trial updates, challenges with gene therapies & unmet needs 11:58

8d ago11:58

11:58

Today’s VJHemOnc podcast features experts Rabi Hanna, MD, The Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, Subarna Chakravorty, MBBS, MRCPCH, FRCPath, PhD, King’s College Hospital NHS Foundation Trust, London, UK, and Ali Taher, MD, PhD, FRCP, American University of Beirut Medical Center, Beirut, Lebanon. They discuss key updates in si…

1
Chikungunya Virus Vaccine: A New Addition to the Travel Vaccine Armamentarium 31:22

2h ago31:22

31:22

Do you know how to identify individuals at risk for chikungunya virus-related disease who may benefit from vaccination? Credit available for this activity expires: 8/29/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001434?ecd=bdc_podcast_libsyn_mscpedu

1
Undercover Partners: HIV, Immune Activation, and Inflammation 27:04

3h ago27:04

27:04

Find out how to assess inflammation in people living with HIV, and how it drives early aging and comorbidities. Credit available for this activity expires: 8/29/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001461?ecd=bdc_podcast_libsyn_mscpedu

1
Episode 50. Quadruplets in Newly Diagnosed Transplant-Ineligible Myeloma with Dr. Timothy Schmidt 41:39

2h ago41:39

41:39

In this episode, we discuss the management of newly diagnosed transplant in-eligible multiple myeloma with Dr. Timothy Schmidt, with a special focus on IMROZ and BENEFIT RCTs testing quadruplets in this space. Here are the key papers we discussed: 1. MAIA trial (Daratumumab-Lenalidomide-Dexamethasone [DRd] vs Rd in newly diagnosed transplant inelig…

1
S1 Ep124: Afami-cel Approval May Open Gateway for Synovial Sarcoma Advancements 11:56

2d ago11:56

11:56

In a conversation with CancerNetwork®, Brian A. Van Tine, MD, PhD, spoke about the FDA accelerated approval of afamitresgene autoleucel (afami-cel; Tecelra) for patients with metastatic or unresectable synovial sarcoma expressing MAGE-A4. He discussed the data from the phase 2 SPEARHEAD-1 trial (NCT04044768) supporting the agent’s use in this patie…

1
Patient-Centered Care in Newly Diagnosed Multiple Myeloma: Navigating Triplet and Quadruplet Therapy 32:22

7h ago32:22

32:22

Did you know that choosing between triplet and quadruplet regimens can make a significant difference in achieving optimal disease outcomes? Credit available for this activity expires: 08/19/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001477?ecd=bdc_podcast_libsyn_mscpedu…

1
Hemophilia updates from ISTH 2024: ongoing clinical trials, emerging gene therapies & remaining challenges 18:41

8d ago18:41

18:41

This week's VJHemOnc podcast brings you updates in hemophilia from the 32nd Congress of the International Society on Thrombosis and Haemostasis (ISTH), held in Bangkok, Thailand, and virtually. You hear from experts Omolade Awodu, MBChB, MD, FMCPath, University of Benin, Benin City, Nigeria, who discusses key hemophilia clinical trials in 2024, Rad…

1
S1 Ep123: Optimizing Benefits Following Dostarlimab Approval in Endometrial Cancer 10:56

3h ago10:56

10:56

CancerNetwork® spoke with Ritu Salani, MD, about the expanded FDA approval of dostarlimab-gxly (Jemperli) in combination with carboplatin/paclitaxel for patients with primary advanced or recurrent endometrial cancer.1 Salani, a board-certified gynecologic oncologist and director of Gynecologic Oncology at the University of California, Los Angeles H…

1
"Voices of Resilience: The Journey of Zale Young" 44:46

11d ago44:46

44:46

In this episode of the Stories to Create Podcast, host Cornell Bunting chats with Zale Young, an up-and-coming reggae artist based in California, striving to break into the music industry with his unique and diverse style. Zale shares his journey of growing up in Kingston with his mother, surrounded by the Rastafarian community in the early 2000s. …

1
Selecting Antiseizure Medications and Aiming for Seizure Freedom 38:05

5d ago38:05

38:05

How to achieve seizure freedom after 2 antiseizure medications (ASMs) fail? Expert insight into best practice Credit available for this activity expires: 8/15/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001425?ecd=bdc_podcast_libsyn_mscpedu

1
Advances in Dermal Fillers: Hybrid Fillers and the Power of Regenerative Biostimulation 32:15

7d ago32:15

32:15

Learn the fundamentals of regenerative aesthetics and how hybrid fillers can help you achieve patient goals. Credit available for this activity expires: 8/15/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001440?ecd=bdc_podcast_libsyn_mscpedu

1
Episode 49. Updates on Low-Risk MDS with Dr. Maximilian Stahl 43:23

13d ago43:23

43:23

In this episode, we discuss updates on low-risk MDS with Dr. Maximilian Stahl with a focus on imetelstat and luspatercept. Here are the trials we discussed: 1. IWG 2019 response criteria https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042664/ 2. MEDALIST trial: Luspatercept https://www.nejm.org/doi/10.1056/NEJMoa1908892?url_ver=Z39.88-2003&rfr_id=ori…

1
Inflammation and immune interventions in MDS: targeting STAT, IRAK4, & more 17:29

23h ago17:29

17:29

In myelodysplastic syndromes (MDS), chronic inflammation driven by the innate immune system plays a key role in disease progression. Signal Transducer and Activator of Transcription (STAT) and Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) are critical mediators in this process, where dysregulated signaling leads to aberrant hematopoiesis and t…

1
S1 Ep122: Taking a “Cross-Cutting Approach” With Cancer Vaccinations 13:49

17d ago13:49

13:49

In a conversation with CancerNetwork®, Catherine J. Wu, MD, spoke about the ongoing development of cancer vaccines as a potentially “cross-cutting” therapeutic strategy for treating patients with cancer. Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies and a Lavine Family Chair for Preventative Cancer Therapies at Dana-…

1
Treatment Goals and Targeted Therapies in Myasthenia Gravis 31:03

1d ago31:03

31:03

Are you up to date on the most recent clinical guidelines and treatment options for myasthenia gravis (MG)? Credit available for this activity expires: 8/6/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001404?ecd=bdc_podcast_libsyn_mscpedu

1
S1 Ep121: Advancing Pancreatic Cancer Care Through Intraoperative Radiation Therapy 28:08

18d ago28:08

28:08

CancerNetwork® spoke with Kamran Idrees, MD, MSCI, MMHC, FACS; Natalie A. Lockney, MD; and Milad Baradaran, PhD, DABR, about the potential utility of intraoperative radiation therapy (IORT) among patients with pancreatic cancer. The group detailed the design and mechanism, gradual technical advancements, and trial data supporting the application of…

1
"From Humble Beginnings to Real Estate: David Harrison's Journey" 51:41

10d ago51:41

51:41

On this episode of the Stories to Create Podcast, Cornell Bunting sits down with real estate mogul David Harrison, who has extensive experience serving customers in Florida, Jamaica, and Georgia. David is committed to providing exceptional service to individuals and families looking to buy, sell, build, invest, or rent. His expertise spans South Fl…

1
The Immersive Immigrant with Lindy Mtongana 1:06:16

14d ago1:06:16

1:06:16

In this episode of the "Home to Here" podcast, we dive into the fascinating journey of Lindy Mtongana, an immersive immigrant from South Africa. Throughout the episode, Lindy provides valuable insights into the immigrant experience, highlighting the importance of community and the unique challenges that come with adapting to a new culture. She also…

1
Managing Diffuse Large B-Cell Lymphoma at First Relapse: Optimizing Patient-Centered Care 38:15

27d ago38:15

38:15

Learn from the experts about aligning treatments with patient expectations at first relapse of diffuse large B-cell lymphoma (DLBCL). Credit available for this activity expires: 7/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001321?ecd=bdc_podcast_libsyn_mscpedu…

1
A transcriptional cofactor‐mediated dependency module 24:48

15d ago24:48

24:48

In this newest podcast episode, Dr Charles de Bock hosts Dr Thomas Mercher and Dr Alexandre Fagnan. This episode is based on their recent paper, “The ETO2 transcriptional co-factor maintains acute leukemia by driving a MYB/EP300-dependent stemness program”, highlighting ETO2 activated gene transcription and how this affects erythroleukemia. The dis…

1
S1 Ep120: Improving CAR T-Cell Therapy Monitoring Strategies and Access in Lymphoma 15:37

1M ago15:37

15:37

In a conversation with CancerNetwork®, Nausheen Ahmed, MD, spoke about optimizing monitoring strategies for patients with B-cell non-Hodgkin lymphoma who undergo treatment with CAR T-cell therapy. Ahmed, an associate professor in the Division of Hematologic Malignancies and Cellular Therapeutics at the University of Kansas Medical Center, discussed…

1
Unmet treatment needs in MF: managing prefibrotic disease & thrombocytopenia, novel agents & endpoints for clinical trials 16:00

15d ago16:00

16:00

Myelofibrosis (MF) is a chronic myeloproliferative neoplasm (MPN) characterized by bone marrow fibrosis, extramedullary hematopoiesis, and splenomegaly, often resulting in anemia and thrombocytopenia. There are many unmet treatment needs that remain in this space. This week’s podcast features a discussion from the International Workshop on Myelodys…

1
"Navigating Paradigm Shifts: A Conversation with Bernard Faithful" 59:19

29d ago59:19

59:19

In this episode of the Stories to Create Podcast, host Cornell Bunting welcomes back repeat guest Bernard Faithful. Born and raised in Michigan, Bernard has traveled the world as a professional athlete. Before his athletic career, he attended the University of Toledo, earning a bachelor's degree in psychology. He later achieved a master’s degree in…

1
Incorporating Lipoprotein(a) Routinely Into Cardiovascular Risk Assessment: Why, What, Who, How, and When? 18:49

1M ago18:49

18:49

Learn from the experts about typical clinical scenarios, guidelines, and practical tips about lipoprotein(a) [Lp(a)]. Credit available for this activity expires: 7/24/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001247?ecd=bdc_podcast_libsyn_mscpedu

1
The Intentional Immigrant with Ehae Longe 1:01:40

1M ago1:01:40

1:01:40

In this insightful episode of Home 2 Here, we sit down with Ehae Longe, a remarkable individual who has navigated cultural transitions from Nigeria to England and then to France. Ehae shares her journey from finishing high school in Lagos to moving to the UK for college, highlighting the challenges and triumphs she faced along the way. She discusse…

1
S1 Ep119: Exploring New Possibilities in Kidney Cancer Detection and Therapy 9:57

22d ago9:57

9:57

At the 2024 Kidney Cancer Research Summit (KCRS), CancerNetwork® spoke with various experts in the kidney cancer field about potential advancements in disease detection and updated efficacy data on immunotherapy and other treatment strategies in patients with renal cell carcinoma (RCC). Karl Semaan, MD, MSc, a postdoctoral oncology research fellow …

1
The role of BTK inhibitors in MCL, ongoing trials & future outlooks: updates from EHA 2024 12:13

22d ago12:13

12:13

The introduction of Bruton's tyrosine kinase (BTK) inhibitors into the treatment landscape for mantle cell lymphoma (MCL) has transformed the field and provided patients with a promising therapeutic option. In this podcast, you will hear from leading experts who discuss the value of these agents in MCL, sharing updates from EHA 2024. Tune in as Man…

1
Episode 48. Management of Polycythemia Vera with Dr. Aaron Gerds 57:09

23d ago57:09

57:09

In this episode, we discussed the diagnosis and management of polycythemia vera with Dr. Aaron T. Gerds. Here are the shownotes with the key studies discussed: 1. MIPS PV scoring system https://pubmed.ncbi.nlm.nih.gov/31945802/ 2. REVEAL study https://ashpublications.org/blood/article/143/16/1646/506717/Association-between-elevated-white-blood-cell…

1
Immunotherapy for Early-Stage Resectable NSCLC: Optimizing Multidisciplinary Management Today 29:49

27d ago29:49

29:49

Clinical trials have reshaped multidisciplinary treatment paradigms for early-stage disease. Is your clinic up to date? Credit available for this activity expires: 7/15/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001332?ecd=bdc_podcast_libsyn_mscpedu

1
S1 Ep118: Overcoming Physical and Social Barriers in the Lymphoma Field 19:14

1M ago19:14

19:14

As part of the Breaking Barriers: Women in Oncology program, CancerNetwork® spoke with Julie M. Vose, MD, MBA, and Avyakta Kallam, MD, about the evolution of their careers in the hematology-oncology space, including some of the critical advances and challenges associated with their work in the lymphoma field. Vose is division chief, Neumann M. and …

1
Novel developments in lower-risk MDS & important practical considerations when treating patients 51:42

29d ago51:42

51:42

In today’s VJHemOnc podcast, we will be sharing novel developments in lower-risk myelodysplastic syndromes (LR-MDS) and important practical considerations when treating patients. You will hear from experts Amer Zeidan, MBBS, Yale University and Yale Cancer Center, New Haven, CT, Rena Buckstein, MD, FRCPC, Odette Cancer Research Program, Sunnybrook …

1
Navigating Life and Music with Paige Knechtly 56:10

2M ago56:10

56:10

In this captivating episode of the Stories to Create Podcast, host Cornell Bunting welcomes the multifaceted Paige Knechtly—an accomplished health advocate, recording artist, and performer. Paige brings a wealth of experience and insight, drawing from her background in health promotion and education at the University of Cincinnati. Paige's journey …

1
Exploring the Value of Delivering Lung Cancer Medicines in Different Ways: Optimizing the Patient Experience 41:57

1M ago41:57

41:57

New subcutaneous (SC) therapies are becoming available in lung cancer. Are you ready to talk to your patients about these? Credit available for this activity expires: 7/10/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001272?ecd=bdc_podcast_libsyn_mscpedu

1
Latest Advances in Breast Cancer Care: Highlights From Chicago 2024 16:37

1M ago16:37

16:37

Missed the last oncology meeting in Chicago or simply want to recap the highlights? This rapid-fire program was made for you! Credit available for this activity expires: 7/9/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001283?ecd=bdc_podcast_libsyn_mscpedu…

1
Updates on the use of BCMA-targeting bispecific antibodies in R/R multiple myeloma: insights from EHA & ASCO 2024 16:18

2M ago16:18

16:18

BCMA-targeting bispecific antibodies treat multiple myeloma by binding to BCMA on malignant plasma cells and directing T-cells to initiate targeted cell killing. This podcast provides updates on the use of BCMA-targeting bispecific antibodies in relapsed/refractory (R/R) multiple myeloma from the 2024 American Society of Clinical Oncology (ASCO) Me…

1
S1 Ep117: Epcoritamab Approval Expands Bispecific Use in Follicular Lymphoma 13:01

2M ago13:01

13:01

Tycel Phillips, MD, spoke with CancerNetwork® ahead of the FDA’s accelerated approval of epcoritamab-bysp (Epkinly) for patients with relapsed/refractory follicular lymphoma to discuss how this agent may impact the treatment paradigm. Phillips, an associate professor in the Division of Lymphoma and Department of Hematology & Hematopoietic Stem Cell…

1
Episode 47. ASCO/EHA 2024 Lymphoma Updates with Dr. Gloria Iacoboni 47:48

2M ago47:48

47:48

In this episode, we reviewed the hottest updates in lymphoma from ASCO and EHA 2024, held in Chicago and Madrid respectively, with Dr. Gloria Iacoboni, a haematologist from University Hospital Vall d'Hebron, in Barcelona, Spain. Here are the key abstracts we discussed: 1. STARGLO: Glofit-GEMOX vs R-GEMOX in relapsed/refractory DLBCL https://library…

1
Unraveling the secrets of thrombopoiesis 25:20

2M ago25:20

25:20

Welcome to Season 2 of our podcast! In this episode, Dr. Francesca Vinchi interviews Professor Alessandra Balduini about thrombopoiesis. They explore Prof. Balduini's journey into research, her intuition that led to silk scaffolding, and her hopes on future results. "Unraveling the secrets of thrombopoiesis", is on our website and all major podcast…

1
Highlights from EHA 2024 - Updates on the Treatment of CLL 42:13

2M ago42:13

42:13

In this podcast episode, three of Canada’s top hematologists discuss data on the treatment of CLL presented at the European Hematology Association (or EHA) meeting in Madrid, Spain. The discussion involves an analysis of the data from 6 oral presentations on combination and novel therapies for the treatment of CLL. In this discussion, the data is p…

1
S1 Ep116: Leveraging Artificial Intelligence Evolutions in Prostate Cancer Care 31:49

2M ago31:49

31:49

In a conversation with CancerNetwork®, James B. Yu, MD, MHS, FASTRO, and Julian C. Hong, MD, MS, spoke about their study titled AI Use in Prostate Cancer: Potential Improvements in Treatments and Patient Care, which was published in the May issue of the journal ONCOLOGY®. Yu is a radiation oncologist in the Department of Radiation Oncology at Smilo…

1
Updates in the treatment of CLL from EHA 2024: BTK and BCL2 inhibitor combinations, BTK degraders, and more 12:10

1M ago12:10

12:10

In today's VJHemOnc podcast, we will be sharing key updates in the treatment of chronic lymphocytic leukemia (CLL) and Richter’s transformation (RT) from the 29th Congress of the European Hematology Association (EHA) in Madrid, Spain. You will hear from experts Toby Eyre, MBChB (Hons), DipMedEd, MRCP (UK), FRCPath (UK), MD, Oxford University Hospit…

1
"From Service to Leadership: Mayor Kevin Anderson's Journey in Community Impact" 1:08:41

2M ago1:08:41

1:08:41

"In this Stories to Create Podcast episode, Cornell Bunting sits down with Fort Myers Mayor Kevin Anderson. Mayor Anderson reflects on his early life, born in Connecticut, recalling childhood challenges such as frequent fights and teasing for his shoes, earning him the nickname 'slum shoe.' He shares pivotal moments, including a supportive encounte…

1
Obesity Care: Improving Health Outcomes in Collaboration With the Patient 35:14

2M ago35:14

35:14

What impact can weight loss have on the lives of your patients living with obesity? What treatment options are available to help you help them? Credit available for this activity expires: 06/28/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001269?ecd=bdc_podcast_libsyn_mscpedu…

1
The Evolution of Incretins – A Revolution in Diabetes Management? 35:55

2M ago35:55

35:55

The expanding world of glucagon-like peptide-1 (GLP-1) receptor antagonism. What do these developments mean for clinical practice? Credit available for this activity expires: 6/27/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001235?ecd=bdc_podcast_libsyn_mscpedu…

1
Dengue: A Leading Cause of Travel-Related Fever – Vaccinating Travelers to Endemic Regions 20:34

2M ago20:34

20:34

Are you up to date on the risk for dengue and how to implement dengue vaccination in travelers to endemic regions? Credit available for this activity expires: 6/25/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001216?ecd=bdc_podcast_libsyn_mscpedu

1
Highlights from ISA 2024: the importance of early diagnosis in AL amyloidosis, trials in progress & patient selection for SCT 8:43

2M ago8:43

8:43

Welcome to today's VJHemOnc podcast episode, where we will be sharing key highlights from the 2024 International Symposium on Amyloidosis (ISA), which was held in Rochester, MN. This podcast covers a variety of unmet needs in light chain (AL) amyloidosis, as well as emerging trials in the field. Join leading experts Mario Nuvolone, MD, PhD, Univers…

1
Unlocking the Power of Tumor-Agnostic Therapy: A Path to Personalized Cancer Care 36:04

2M ago36:04

36:04

Are you aware of the currently approved tumor-agnostic drugs? Listen to the experts as they discuss them. Credit available for this activity expires: 06/21/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001234?ecd=bdc_podcast_libsyn_mscpedu

1
S1 Ep115: Ensuring Quality Outcomes in Hematologic Cancer Subgroups at EHA 2024 8:13

2M ago8:13

8:13

At the 2024 European Hematology Association (EHA) Congress, CancerNetwork® spoke with a variety of experts in the hematologic oncology space about optimizing outcomes across different patient populations and subgroups based on updated research they presented at the meeting. Manali Kamdar, MD, an associate professor of medicine-hematology and clinic…

1
LIVE FROM EHA 2024 - Sonrotoclax plus Zanubrutinib in R/R CLL 16:33

2M ago16:33

16:33

In this episode of our podcast, recorded at the European Hematology Association (EHA) meeting in Madrid, Spain, we discuss updated results of the BGB-11417-101 trial with Dr. Stephen Opat. The BGB-11417-101 trial examined the efficacy and safety of sonrotoclax plus zanubrutinib for the treatment of R/R CLL. Our Guest: Dr. Stephen Opat is the direct…

Podcasts Worth a Listen

EHA Podcasts

Podcasts Worth a Listen

Quick Reference Guide